DSM halts animal grade Vitamin A and reduces Vitamin E production

86

Royal DSM, a global purpose-led science-based company, today announces a halt to Rovimix® Vitamin A production in Sisseln, Switzerland, for at least 2 months commencing January 2, 2023. Rovimix® Vitamin E-50 production will be significantly impacted as well due to its common upstream infrastructure. 

At the start of the month November, DSM communicated to clients the necessity to enact price increases for its high-quality vitamins to justify continuation of production in Europe in the current challenging cost environment. With higher energy costs foreseen this winter, DSM has decided to halt Rovimix® Vitamin A production in Sisseln, Switzerland, which also impacts Rovimix® Vitamin E-50 production.

Existing contractual commitments will be honored and allocation procedures have been activated across the global production network to enact this in an orderly manner.

DSM is committed to sustainable production of the highest quality feed additives, including the longstanding Rovimix® product range produced in Sisseln, Switzerland, provided that aligns with our aim to generate sustainable profitable growth.